Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXUW1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,385
Award facts
- Contract value 100% obligated
- $55,385.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $55.4K delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens (2 mL units) with an ultimate completion date of January 23, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and will be performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen) and serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems.
This delivery order operates under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.999B through December 2026), which functions as a comprehensive global pharmaceutical support vehicle. The parent IDC enables the contractor to supply a broad range of pharmaceutical products, medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including service to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Dupixent is a specialty biologic medication used in the treatment of atopic dermatitis and other inflammatory conditions, representing the type of specialized pharmaceutical commodity critical to federal medical supply chains.
Quick answers
Who was awarded contract SPE2DR26FXUW1?
SPE2DR26FXUW1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FXUW1 worth?
The government has obligated $55,385 on SPE2DR26FXUW1.
Is contract SPE2DR26FXUW1 an order under another contract?
Yes. SPE2DR26FXUW1 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXUW1 competed?
The extent of competition for SPE2DR26FXUW1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award